White label – Pompe disease - ClinicalTrials.eu

Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

Not recruiting

3 1 1 1
Investigated Diseases:
- Primary myelofibrosis
- Myelofibrosis
Investigated Drugs:
+2
Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

Not recruiting

3 1 1
Investigated Diseases:
- Primary amyloidosis
Investigated Drugs:
+8
Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ibrutinib
+6
Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

Not recruiting

3 1 1
Investigated Diseases:
- Niemann-Pick disease
Investigated Drugs:
- Hydroxypropylbetadex
- Miglustat
Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

Not recruiting

3 1 1
Investigated Diseases:
- Psoriatic arthropathy
Investigated Drugs:
- Bimekizumab
- Risankizumab
Study on the Effects of Povetacicept for Adults with IgA Nephropathy

Not recruiting

3 1
Investigated Diseases:
- Nephropathy
Investigated Drugs:
- Povetacicept
+13
Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Not recruiting

4 1 1 1
Investigated Diseases:
- Macular oedema
- Diabetic retinal oedema
Investigated Drugs:
+6
Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

Not recruiting

2 1 1
Investigated Diseases:
- Skin cancer
- Basal cell carcinoma
Investigated Drugs:
- Balstilimab
Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

Not recruiting

3 1 1
Investigated Drugs:
- Empagliflozin
Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Morf-057

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies